Scientific/Clinical Conferences
CorMedix presented data from the EU post-approval Neutrolin® Use Monitoring Program (NUMP study).
The National Kidney Foundation in Dallas, Texas on March 28, 2015 by Dr. Christoph Wanner, Professor of Medicine and Head of the Renal Division at the University or Wurzburg, Germany
9th Congress of the Vascular Access Society in Barcelona, Spain on April 17, 2015 presented by Dr. Markus Hollenbeck, Professor, Doctor of Medicine at Department of Nephrology and Intensive Care Medicine at Knappschaftskrankenhaus Bottrop, Germany
52nd Congress of the European Renal Associations in London, United Kingdom, May 28-31, 2015.
ABSTRACTS
Neutrolin, A Catheter Lock Solution (CLS) with No Reported Human Resistance, Significantly Reduces the Rates of Infection and Thrombosis in Hemodialysis Patients Enrolled in a Post-Approval Surveillance Study, 52nd European Dialysis and Transplant Association (ERA-EDTA) Congress. Poster Number: SP593
